Preventive effects of epigallocatechin-3- O -gallate against replicative senescence associated with p53 acetylation in human dermal fibroblasts

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Han, Dong Wook ^a   Lee, Mi Hee ^b   Kim, Bongju ^c   Lee, Jun Jae ^a,d   Hyon, Suong Hyu ^d   Park, Jong Chul ^b  

^a Pusan National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-AGING; ANTI-INFLAMMATORIES; ANTIDIABETIC; CELL-CYCLE PROGRESSION; CELLULAR UPTAKE; DIFFERENTIAL RESPONSE; GALLATE; HUMAN ARTICULAR CHONDROCYTES; HUMAN DERMAL FIBROBLASTS; NUCLEAR TRANSLOCATIONS; PHARMACOLOGICAL ACTIVITY; PRIMARY CELLS; REPLICATIVE SENESCENCE; UNDERLYING MECHANISM; VASCULAR SMOOTH MUSCLE CELLS;

CELLS; CYTOLOGY; ORGANIC POLYMERS;

ACETYLATION;

EPIGALLOCATECHIN GALLATE; FLUORESCEIN ISOTHIOCYANATE; HYDROGEN PEROXIDE; PROTEIN P53; SIRTUIN 1; BETA GALACTOSIDASE; CATECHIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DRUG DERIVATIVE; PROTECTIVE AGENT; SIRT1 PROTEIN, HUMAN;

ACETYLATION; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CARTILAGE CELL; CELL AGING; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL NUCLEUS; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOPLASM; DRUG RESPONSE; HUMAN; HUMAN CELL; IC 50; MALE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SKIN FIBROBLAST; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CELL CYCLE; CELL DEATH; CELL PROTECTION; CYTOLOGY; DERMIS; DRUG EFFECT; FIBROBLAST; FLUORESCENCE MICROSCOPY; METABOLISM;

RATTUS;

ACETYLATION; ANIMALS; BETA-GALACTOSIDASE; CATECHIN; CELL AGING; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPROTECTION; DERMIS; FIBROBLASTS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; HYDROGEN PEROXIDE; INHIBITORY CONCENTRATION 50; MICROSCOPY, FLUORESCENCE; PROTECTIVE AGENTS; RATS; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84871367411     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/850684     Document Type: Article

References (46)

1. Hayflick L., Moorhead P. S., The serial cultivation of human diploid cell strains. Experimental Cell Research 1961 25 3 585 621 2-s2.0-0344622606
2. Collado M., Blasco M. A., Serrano M., Cellular senescence in cancer and aging. Cell 2007 130 2 223 233 2-s2.0-34447543913 10.1016/j.cell.2007.07.003 (Pubitemid 47081143)
3. Park S.-J., Ahmad F., Philp A., Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012 148 3 421 433 10.1016/j.cell.2012.01.017
4. Allard J. S., Perez E., Zou S., de Cabo R., Dietary activators of Sirt1. Molecular and Cellular Endocrinology 2009 299 1 58 63 2-s2.0-58349102337 10.1016/j.mce.2008.10.018
5. Blagosklonny M. V., An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discovery Today 2007 12 5-6 218 224 2-s2.0-33847226657 10.1016/j.drudis.2007.01.004
6. Howitz K. T., Bitterman K. J., Cohen H. Y., Lamming D. W., Lavu S., Wood J. G., Zipkin R. E., Chung P., Kisielewski A., Zhang L. L., Scherer B., Sinclair D. A., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 425 6954 191 196 2-s2.0-0141719702 10.1038/nature01960 (Pubitemid 37150899)
7. Mak J. C., Potential role of green tea catechins in various disease therapies: progress and promise. Clinical and Experimental Pharmacology and Physiology 2012 39 3 265 273 10.1111/j.1440-1681.2012.05673.x
8. Ahmed S., Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise. Arthritis Research and Therapy 2010 12 2, article 208 2-s2.0-77956991865 10.1186/ar2982
9. Pandey K. B., Rizvi S. I., Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Medicine and Cellular Longevity 2009 2 5 270 278 2-s2.0-77953474824 10.4161/oxim.2.5.9498
10. Obrenovich M. E., Nair N. G., Beyaz A., Aliev G., Reddy V. P., The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Research 2010 13 6 631 643 2-s2.0-78651341862 10.1089/rej.2010.1043
11. Queen B. L., Tollefsbol T. O., Polyphenols and aging. Current Aging Science 2010 3 1 34 42 2-s2.0-77953762857 10.2174/1874609811003010034
12. Kim J. A., Mechanisms underlying beneficial health effects of tea catechins to improve insulin resistance and endothelial dysfunction. Endocrine, Metabolic and Immune Disorders 2008 8 2 82 88 2-s2.0-47249093164 10.2174/187153008784534349
13. Bulku E., Zinkovsky D., Patel P., Javia V., Lahoti T., Khodos I., Stohs S. J., Ray S. D., A novel dietary supplement containing multiple phytochemicals and vitamins elevates hepatorenal and cardiac antioxidant enzymes in the absence of significant serum chemistry and genomic changes. Oxidative Medicine and Cellular Longevity 2010 3 2 129 144 2-s2.0-77953711324 10.4161/oxim.3.2.11157
14. Mandel S. A., Amit T., Weinreb O., Youdim M. B. H., Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases. Journal of Alzheimer's Disease 2011 25 2 187 208 2-s2.0-79960722781 10.3233/JAD-2011-101803
15. Stangl V., Lorenz M., Stangl K., The role of tea and tea flavonoids in cardiovascular health. Molecular Nutrition and Food Research 2006 50 2 218 228 2-s2.0-33644641285 10.1002/mnfr.200500118 (Pubitemid 43325662)
16. Shanmugam M. K., Kannaiyan R., Sethi G., Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutrition and Cancer 2011 63 2 161 173 2-s2.0-79951901778 10.1080/01635581.2011.523502
17. Pan M. H., Lai C. S., Dushenkov S., Ho C. T., Modulation of inflammatory genes by natural dietary bioactive compounds. Journal of Agricultural and Food Chemistry 2009 57 11 4467 4477 2-s2.0-67149146566 10.1021/jf900612n
18. Bae J. Y., Kanamune J., Han D. W., Matsumura K., Hyon S. H., Reversible regulation of cell cycle-related genes by epigallocatechin gallate for hibernation of neonatal human tarsal fibroblasts. Cell Transplantation 2009 18 4 459 469 2-s2.0-67651244954 10.3727/096368909788809776
19. Cho H. H., Han D. W., Matsumura K., Tsutsumi S., Hyon S. H., The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide- co-ε -caprolactone) as stent-coating materials. Biomaterials 2008 29 7 884 893 2-s2.0-37249035074 10.1016/j.biomaterials.2007.10.052 (Pubitemid 350266055)
20. Bae J. Y., Han D. W., Matsumura K., Wakitani S., Nawata M., Hyon S. H., Nonfrozen preservation of articular cartilage by epigallocatechin-3-gallate reversibly regulating cell cycle and nf- B expression. Tissue Engineering A 2010 16 2 595 603 2-s2.0-77049118334 10.1089/ten.tea.2009.0484
21. Han D. W., Lee M. H., Kim H. H., Hyon S. H., Park J. C., Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor- B in human dermal fibroblasts. Acta Pharmacologica Sinica 2011 32 5 637 646 2-s2.0-79959740010 10.1038/aps.2011.17
22. Marcotte R., Lacelle C., Wang E., Senescent fibroblasts resist apoptosis by downregulating caspase-3. Mechanisms of Ageing and Development 2004 125 10-11 777 783 2-s2.0-8344230643 10.1016/j.mad.2004.07.007 (Pubitemid 39482406)
23. Han D. W., Matsumura K., Kim B., Hyon S. H., Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3- O -gallate in L-929 cells. Bioorganic and Medicinal Chemistry 2008 16 22 9652 9659 2-s2.0-54849438917 10.1016/j.bmc.2008.10.009
24. Meng Q., Velalar C. N., Ruan R., Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast. Free Radical Biology and Medicine 2008 44 6 1032 1041 2-s2.0-39949085055 10.1016/j.freeradbiomed.2007.11.023
25. Ben-Porath I., Weinberg R. A., When cells get stressed: an integrative view of cellular senescence. Journal of Clinical Investigation 2004 113 1 8 13 2-s2.0-1542781659 10.1172/JCI200420663 (Pubitemid 38541623)
26. Lee J. H., Chung K. Y., Bang D., Lee K. H., Searching for aging-related proteins in human dermal microvascular endothelial cells treated with anti-aging agents. Proteomics 2006 6 4 1351 1361 2-s2.0-33644554186 10.1002/pmic.200500287
27. Cristofalo V. J., Phillips P. D., Sorger T., Gerhard G., Alterations in the responsiveness of senescent cells to growth factors. Journals of Gerontology 1989 44 6 55 62 2-s2.0-0024423686 (Pubitemid 19282269)
28. Dulic V., Drullinger L. F., Lees E., Reed S. I., Stein G. H., Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proceedings of the National Academy of Sciences of the United States of America 1993 90 23 11034 11038 2-s2.0-0027332123 10.1073/pnas.90.23.11034 (Pubitemid 23354363)
29. Brown J. P., Wei W., Sedivy J. M., Bypass of senescenoe after disruption of p21(CIP1)/(WAF1) gene in normal diploid human fibroblasts. Science 1997 277 5327 831 834 2-s2.0-0030609861 10.1126/science.277.5327.831 (Pubitemid 27366737)
30. Stein G. H., Drullinger L. F., Robetorye R. S., Pereira-Smith O. M., Smith J. R., Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proceedings of the National Academy of Sciences of the United States of America 1991 88 24 11012 11016 2-s2.0-0026322601 (Pubitemid 21915969)
31. Lee M. H., Han D. W., Hyon S. H., Park J. C., Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3- O -gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor- B. Apoptosis 2011 16 1 75 85 2-s2.0-79951551609 10.1007/s10495-010-0548- y
32. Kume S., Haneda M., Kanasaki K., Sugimoto T., Araki S. I., Isono M., Isshiki K., Uzu T., Kashiwagi A., Koya D., Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radical Biology and Medicine 2006 40 12 2175 2182 2-s2.0-33745166337 10.1016/j.freeradbiomed.2006.02.014 (Pubitemid 43903102)
33. Cohen H. Y., Miller C., Bitterman K. J., Wall N. R., Hekking B., Kessler B., Howitz K. T., Gorospe M., De Cabo R., Sinclair D. A., Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004 305 5682 390 392 2-s2.0-3142740860 10.1126/science.1099196 (Pubitemid 38938153)
34. Kennedy B. K., Steffen K. K., Kaeberlein M., Ruminations on dietary restriction and aging. Cellular and Molecular Life Sciences 2007 64 11 1323 1328 2-s2.0-34249980038 10.1007/s00018-007-6470-y (Pubitemid 46889228)
35. Pallàs M., Verdaguer E., Tajes M., Gutierrez-Cuesta J., Camins A., Modulation of sirtuins: New targets for antiageing. Recent Patents on CNS Drug Discovery 2008 3 1 61 69 2-s2.0-38949185264 10.2174/157488908783421492 (Pubitemid 351223186)
36. Srivastava S., Haigis M. C., Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases. Current Pharmaceutical Design 2011 17 31 3418 3433 10.2174/138161211798072526
37. Kelly G. S., A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2. Alternative Medicine Review 2010 15 4 313 328 2-s2.0-79952265133
38. Loeser R. F., Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis and Cartilage 2009 17 8 971 979 2-s2.0-67650383738 10.1016/j.joca.2009.03.002
39. Martin J. A., Buckwalter J. A., Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002 3 5 257 264 2-s2.0-0036398455 10.1023/A:1020185404126 (Pubitemid 35174238)
40. 2-induced senescent phenotype and cell cycle arrest in normal human diploid fibroblasts. Experimental Cell Research 2004 298 1 188 196 2-s2.0-3042778581 10.1016/j.yexcr.2004.04.012 (Pubitemid 38887318)
41. + depletion. Cellular Physiology and Biochemistry 2007 20 1-4 45 54 2-s2.0-34250758020 10.1159/000104152 (Pubitemid 46956811)
42. Afanas'ev I., Reactive oxygen species and age-related genes p66shc, Sirtuin, FOX03 and Klotho in senescence. Oxidative medicine and cellular longevity 2010 3 2 77 85 2-s2.0-77957341040
43. Okabe S., Suganuma M., Hayashi M., Sueoka E., Komori A., Fujiki H., Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Japanese Journal of Cancer Research 1997 88 7 639 643 2-s2.0-0030847456 (Pubitemid 27394047)
44. Hong J., Lu H., Meng X., Ryu J. H., Hara Y., Yang C. S., Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Research 2002 62 24 7241 7246 2-s2.0-0037115556 (Pubitemid 36025245)
45. Tachibana H., Koga K., Fujimura Y., Yamada K., A receptor for green tea polyphenol EGCG. Nature Structural and Molecular Biology 2004 11 4 380 381 2-s2.0-1842525199 10.1038/nsmb743 (Pubitemid 38436804)
46. Lambert J. D., Lee M. J., Lu H., Meng X., Hong J. J. J., Seril D. N., Sturgill M. G., Yang C. S., Epigallocatechin-3-Gallate is absorbed but extensively glucuronidated following oral administration to mice. Journal of Nutrition 2003 133 12 4172 4177 2-s2.0-0345168968 (Pubitemid 37505494)